Star Imaging SME GMP - Live Grey Market Premium
Alloted
Star Imaging & Path Lab Ltd. is a healthcare service provider that offers comprehensive diagnostic imaging services and clinical laboratory tests, including both routine and specialized tests. The company's services span across various medical fields such as Radiology (X-ray, CT Scan, Mammography, 4D ultrasound, Bone Mineral Density), Pathology (Haematology, Microbiology, PCR, Histopathology, Immunology & Bio Chemistry), and Cardio-diagnostics. The company operates on a mixed business model, serving B2G (Public-private partnership model), B2C (direct consumers), and B2B (private hospitals) segments. In Fiscal 2024, B2G contributed 58.46% of the revenue, B2C 34.67%, and B2B 6.87%.
IPO Details
GMP Timeline
| Date | IPO Price | GMP | Est. Price | % Change |
|---|---|---|---|---|
13 Aug 2025Live | 142 | 2 | 144 | +1.41 |
12 Aug 2025 | 142 | 3 | 145 | +2.11 |
11 Aug 2025 | 142 | 0 | 142 | 0.00 |
10 Aug 2025 | 142 | 0 | 142 | 0.00 |
9 Aug 2025 | 142 | 0 | 142 | 0.00 |
8 Aug 2025 | 142 | 0 | 142 | 0.00 |
7 Aug 2025 | 142 | 0 | 142 | 0.00 |
6 Aug 2025 | 142 | 0 | 142 | 0.00 |
5 Aug 2025 | 142 | 0 | 142 | 0.00 |
Important Notes About Grey Market Premium
Grey Market Premium (GMP) is an unofficial value that indicates investor sentiment before the IPO listing. It is the premium amount at which IPO shares are traded in the grey market before they are officially listed on the stock exchange.
GMP fluctuates based on market conditions and investor sentiment. A positive GMP suggests the market expects the stock to list above its issue price, while a negative GMP suggests it may list below the issue price.
The actual listing price may differ from the estimated price based on GMP due to market conditions on the listing day. GMP is not an official indicator and should not be the sole basis for investment decisions.
IPOwiz updates the GMP values regularly, but these values are sourced from unofficial channels and should be used as a reference only.